Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 8,070 shares at $46.42 ($379K) on 2025-01-02, disclosed to the SEC on 2025-01-03.
Scheduled sale ($379k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.42 | 1,499 | $70K | 18.4% |
| 2 | $46.42 | 1,499 | $70K | 18.4% |
| 3 | $47.21 | 2,486 | $117K | 31.0% |
| 4 | $47.21 | 2,486 | $117K | 31.0% |
| 5 | $47.92 | 100 | $5K | 1.3% |
| Total | $46.93 avg | 8,070 |
| $379K |
| 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |